Diagnosis, Management and Modeling of Neurodevelopmental Disorders

The Neuroscience of Development

1st Edition - May 29, 2021
Editors: Colin R Martin, Victor R Preedy, Rajkumar Rajendram
Language: English
Hardback ISBN:
9 7 8 - 0 - 1 2 - 8 1 7 9 8 8 - 8
eBook ISBN:
9 7 8 - 0 - 1 2 - 8 1 7 9 8 9 - 5

Diagnosis, Management and Modeling of Neurodevelopmental Disorders: The Neuroscience of Development is a comprehensive reference on the diagnosis and management of neurodeve… Read more

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Diagnosis, Management and Modeling of Neurodevelopmental Disorders: The Neuroscience of Development is a comprehensive reference on the diagnosis and management of neurodevelopment and associated disorders. The book discusses the mechanisms underlying neurological development and provides readers with a detailed introduction to the neural connections and complexities in biological circuitries, as well as the interactions between genetics, epigenetics and other micro-environmental processes. In addition, the book also examines the pharmacological and non-pharmacological interventions of development-related conditions.

I. Introductory chapters: Setting the scene for the neuroscience of development

1. The structure of the human brain as revealed in six histological sections
Richard Armstrong

2. Neural tube defects: embryonic origin, cell survival equilibrium impact, and clinical features
Chiara Parodi, Paolo Grazioli, Laura Avagliano, Timothy M. George, Gaetano P. Bulfamante, Richard H. Finnell and Valentina Massa

3. Chemical substances affecting neurodevelopment
Munekazu Komada

4. High-risk babies and neurodevelopmental outcome
Merina Shrestha

5. Genomic imprinting and neurodevelopment
Ines Lopez del Castillo, Anna Lozano-Ureña and Sacri R. Ferron

6. Insights from model systems: alcohol, neurodevelopment and zebrafish
Robert Gerlai

7. Maternal iodine nutrition and neurodevelopment in the offspring
Shao Jia Zhou

8. Endocrine aspects of development. Thyroid hormone actions in neurological processes during brain development
Ana Montero-Pedrazuela, Carmen Grijota-Martınez, Eva Auso, Soledad Barez-Lopez and Ana Guadaño-Ferraz

II. Impairments and Diseases

9. Pediatric brain tumors
Sherif G. Shaaban and Stephanie A. Terezakis

10. Neurofibromatosis type 1: from cellular phenotypes to human brain function
Ines Bernardino, Joana Goncxalves and Miguel Castelo-Branco

11. Current insights into neural crest cell development and pathologies
Rebekah M. Charney, Maneeshi S. Prasad and Martın I. Garcıa-Castro

12. Spina Bifida: a biopsychosocial perspective
Diana M. Ohanian, Adrien M. Winning, Laura M. Nicholson and Grayson N. Holmbeck

13. Diabetic ketoacidosis and neurodevelopment
Walter Zegarra and Tandy Aye

14. Four-dimensional features of fetal brain: applications to diabetes
Panagiotis Antsaklis, George Daskalakis and Asim Kurjak

15. Developmental effects of nicotine on cognitive, motivated, and executive behaviors
Kristi A. Kohlmeier and Filip S. Polli

16. Maternal methamphetamine and impact on the developing brain
Romana Slamberova and Kateryna Nohejlova

17. Alcohol, cannabis and brain development
Kristen Rian Breit

18. The environmental pollutant trichloroethylene disrupts key neural pathways during brain development
Briana R. De Miranda and Sarah J. Blossom

19. Developmental neurotoxicity of the herbicide atrazine
Janiel Ahkin Chin Tai and Jennifer L. Freeman

20. Neurodevelopmental delays and in utero exposure to hyperemesis gravidarum
Marlena S. Fejzo and Patrick M. Mullin

21. Neurodevelopment and PCDH19-related developmental and epileptic encephalopathy (PCDH19-DDE)
Silvia Bassani, Carla Marini and Maria Passafaro

22. Neurodevelopment in turner syndrome
Reid Blanchett and Rebecca C. Knickmeyer

23. Very preterm children and the impact on neurodevelopmental outcomes
Leona Pascoe and Peter J. Anderson

24. Linking congenital heart disease and brain functional connectivity in newborns
Josepheen De Asis-Cruz and Catherine Limperopoulos

25. Brain growth in congenital heart disease from prenatal environment to adulthood
Cynthia Ortinau

26. Adolescent dopamine development: connecting experience with vulnerability or resilience to psychiatric disease
Lauren M. Reynolds and Cecilia Flores

27. Developmental coordination disorder
Jill Glennis Zwicker

III. Biomarkers, screening, methods and diagnosis

28. Neurodevelopment and the Ages and Stages Questionnaire, third edition (ASQ-3)
N. Granana and A.M. Romero Otalvaro

29. Attention deficit hyperactivity disorder screening in childhood and adolescence
Steven James Korzeniewski

30. The Mini-Mental State Pediatric Examination: a cognitive screening test for Italian children
Valeria Peviani, Pina Scarpa and Gabriella Bottini

31. Predictors of neurodevelopment in preterm infants: from the neonatal intensive care unit into adulthood
Pilar Medina-Alva

32. Antenatal fetal neurodevelopment test: KANET assessment
Toshiyuki Hata and Mohamed Ahmed AboEllail

IV: Management and treatments

33. Pain evaluation and management in neurodevelopmental conditions
Marlon L. Wong and Eva Widerstrom-Noga

34. Use of levetiracetam in neonates: features and applications (a narrative review)
Shannon Pollock and Louis N. Manganas

35. Quetiapine treatment in paediatric scenarios
Barbara Plemeniti Tololeski and Maja Drobnic Radobuljac

36. Treatments with cannabinoids and brain development
P. Schonhofen, D.M. Vargas, R.B. Parsons and Fabio Klamt

37. Deep brain stimulation for pediatric dystonia: neurophysiological, behavioral, and functional changes and their clinical relevance
Lior M. Elkaim and George M. Ibrahim

38. Use of repetitive transcranial magnetic stimulation in neurodevelopment: A narrative review
Yoshihiro Noda

39. Cognitive behavioral therapy in children with anxiety disorders
Gabrielle Gloston, Michael A. Sustaita, Ana C. Ramirez, Saira A. Weinzimmer, Andres G. Viana, Eric A. Storch and Sophie C. Schneider

40. Cognitive behavioral therapy for anxiety in children with autism spectrum disorder
Ana C. Ramirez, Mayra I. Perez, Danica Limon, Eric A. Storch and Sophie C. Schneider

41. Nutritional treatment in fetal alcohol spectrum disorder (FASD)
Oscar Garcıa-Algar, Giorgia Sebastiani, Vicente Andreu- Ferna
42. Nurturing the developing brain to reduce neurological delay
Kelly A. Vaughn, Bartlett D. Moore, IV and Dana DeMaster

43. Normalizing perinatal neurological development via intervention
Dana DeMaster, Kelly A. Vaughn and Bartlett D. Moore, IV

V. Models and modelling

44. Microplatforms as a model for neurological conditions
George Deeb, Zeina Bou Diab, Jessica Saliba, Arij Daou and Rami Mhanna

45. Disease models in neurodevelopmental disorders
Pietro Fazzari, Angela Rodriguez-Prieto and Maximo Ibo Galindo

46. Developmental neurotoxicity of endosulfan: modeling with zebrafish
Karina Dale, Josef Daniel Rasinger and Ståle Ellingsen

47. Neurodevelopment of the zebrafish spinal serotonin system
Mark A. Masino and Jacob E. Montgomery

48. Inbred mouse model of brain development and intestinal microbiota
Reinaldo B. Oria, Daniel V. Pinto, Ronaldo P. Dias, Ramon S. Raposo, Patricia L. Foley, Joaeo O. Malva and Richard L. Guerrant

49. The myelin mutant taiep rat as a model for developmental brain disorders
Jose R. Eguibar, Carmen Cortes, Juan C. Ahumada-Juarez, Valeria Piazza and Victor Hugo Hernandez Gonzalez

50. The MAM-E17 neurodevelopmental model of schizophrenia
Marzena Mackowiak

VI. Resources

51. Recommended resources on the neuroscience of development
Rajkumar Rajendram and Victor R. Preedy

Colin R Martin

Colin R. Martin RN, BSc, MSc, PhD, MBA, YCAP, FHEA, C.Psychol, AFBPsS, C.Sci is Professor of Clinical Psychobiology and Applied Psychoneuroimmunology and Clinical Director of the Institute of Health and Wellbeing at the University of Suffolk, UK. He is a Chartered Health Psychologist and a Chartered Scientist. He also trained in analytical biochemistry, this aspect reflecting the psychobiological focus of much of his research within mental health. He has published or has in press well over 300 research papers and book chapters. He is a keen book author and editor having written and/or edited more than 50 books. These outputs include the prophetic insight into the treatment of neurological disease, Handbook of Behavior, Food and Nutrition (2011), Nanomedicine and the Nervous System (2012), Oxidative Stress and Dietary Antioxidants in Neurological Disease (2020), Zika Virus Impact, Diagnosis, Control and Models (2021), Factors Affecting Neurodevelopment: Genetics, Neurology, Behavior and Diet (2021), Diagnosis and Treatment of Spinal Cord Injury (2022), The Neurobiology, Physiology, and Psychology of Pain (2022) and The Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging (2023). Professor Martin is particularly interested in all aspects of the relationship between underlying physiological substrates and behavior, particularly in how these relationships manifest in both acute and chronic psychiatric disorder. He has published original research germane to significant mental health disorders including the areas of schizophrenia, anxiety, depression, self-esteem, alcohol and drug dependency, high secure forensic mental health and personality disorder. He has a keen interest in the impact of postviral illness and is actively involved in clinical research post-Covid pandemic and in particular, the impact of Long Covid on psychological, neurological, physiological and social functioning. He is involved in collaborative International research with many European and Non-European countries.

Affiliations and expertise

Professor of Clinical Psychobiology and Applied Psychoneuroimmunology and Clinical Director: Institute for Health and Wellbeing, University of Suffolk, Ipswich, UK

Victor R Preedy

Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.

Affiliations and expertise

Professor, Department of Clinical Biochemistry, King’s College Hospital, London, UK; Emeritus Professor, Faculty of Life Sciences and Medicine, King’s College London, UK Visiting Professor, University of Hull, UK

Rajkumar Rajendram

Dr Rajkumar Rajendram is a clinician scientist with a focus on internal medicine, anaesthesia, intensive care and peri-operative medicine. He graduated with distinctions from Guy’s, King’s and St. Thomas Medical School, King’s College London in 2001. As an undergraduate he was awarded several prizes, merits and distinctions in pre-clinical and clinical subjects.

Dr Rajendram began his post-graduate medical training in general medicine and intensive care in Oxford. He attained membership of the Royal College of Physicians (MRCP) in 2004 and completed specialist training in acute and general medicine in Oxford in 2010. Dr Rajendram subsequently practiced as a Consultant in Acute General Medicine at the John Radcliffe Hospital, Oxford.

Dr Rajendram also trained in anaesthesia and intensive care in London and was awarded a fellowship of the Royal College of Anaesthetists (FRCA) in 2009. He completed advanced training in regional anaesthesia and intensive care. He was awarded a fellowship of the Faculty of Intensive Care Medicine (FFICM) in 2013 and obtained the European diploma of intensive care medicine (EDIC) in 2014. He then moved to the Royal Free London Hospitals as a Consultant in Intensive Care, Anaesthesia and Peri-operative Medicine. He has been a fellow of the Royal College of Physicians of Edinburgh (FRCP Edin) and the Royal College of Physicians of London (FRCP Lond) since 2017 and 2019 respectively. He is currently a Consultant in Internal Medicine at King Abdulaziz Medical City, National Guard Heath Affairs, Riyadh, Saudi Arabia.

Dr Rajendram’s focus on improving outcomes from Coronavirus Disease 2019 (COVID-19) has involved research on point of care ultrasound and phenotypes of COVID-19. Dr Rajendram also recognises that nutritional support is a fundamental aspect of medical care. This is particularly important for patients with COVID-19. As a clinician scientist he has therefore devoted significant time and effort into nutritional science research and education. He is an affiliated member of the Nutritional Sciences Research Division of King’s College London and has published over 400 textbook chapters, review articles, peer-reviewed papers and abstracts.

Affiliations and expertise

Consultant in Internal Medicine, King Abdulaziz Medical City, National Guard Heath Affairs, Riyadh, Saudi Arabia